...
首页> 外文期刊>International Journal of Clinical and Experimental Medicine >The prognostic value of miR-34a expression in completely resected gastric cancer: tumor recurrence and overall survival
【24h】

The prognostic value of miR-34a expression in completely resected gastric cancer: tumor recurrence and overall survival

机译:miR-34a表达在完全切除的胃癌中的预后价值:肿瘤复发和总生存

获取原文
           

摘要

The prognosis of gastric cancer is mainly linked to tumor recurrence. MicroRNA-34a (miR-34a) is a direct transcriptional target of p53 and links tumor suppressor function and the oncogenic pathways in some cancers. However, the role of miR-34a in predicting prognosis of gastric cancer has not been fully elucidated. In this study, we aimed to investigate the expression level of miR-34a and its prognostic value in gastric cancer. A total of 137 consecutive gastric cancer patients who underwent gastrectomy with D2 lymph node dissection were included in this study. Quantitative real-time polymerase chain reaction (qRT-PCR) was utilized to detect miR-34a expression in gastric cancer tissues and adjacent normal tissues. The results showed that the levels of miR-34a expression were significantly decreased in the tumor tissues compared with the adjacent normal tissues (emP/em<0.001). Low miR-34a expression level was associated with lymph node involvement (emP/em=0.004), advanced TNM stage (emP/em=0.006), poor tumor differentiation (emP/em=0.024), high tumor recurrence rate (emP/em=0.008), and poor five-year survival (emP/em<0.001). The median time to recurrence and median overall survival time were significantly shorter in patients with low miR-34a levels compared with those with high miR-34a levels (emP/em=0.028 and emP/em=0.021, respectively). Furthermore, when analyzed with a multivariate Cox regression model, a low miR-34a level was significantly correlated with high recurrence rate and poor overall survival. Taken together, our results suggest that downregulation of miR-34a in gastric cancer is associated with high recurrence rate and poor overall survival and that miR-34a may be served as a prognostic marker for gastric cancer.
机译:胃癌的预后主要与肿瘤复发有关。 MicroRNA-34a(miR-34a)是p53的直接转录靶标,在某些癌症中与肿瘤抑制功能和致癌途径相关。然而,尚未完全阐明miR-34a在预测胃癌预后中的作用。在这项研究中,我们旨在研究miR-34a的表达水平及其在胃癌中的预后价值。本研究共纳入了137例接受D2淋巴结清扫术的胃切除术的连续胃癌患者。实时定量聚合酶链反应(qRT-PCR)用于检测miR-34a在胃癌组织和邻近正常组织中的表达。结果显示,与邻近的正常组织相比,肿瘤组织中的miR-34a表达水平显着降低( P &#x0003c; 0.001)。 miR-34a低表达与淋巴结受累( P = 0.004),晚期TNM分期( P = 0.006),肿瘤分化不良( P < /em>=0.024),较高的肿瘤复发率( P = 0.008)和较差的五年生存率( P &#x0003c; 0.001)。低miR-34a水平的患者的中位复发时间和中位总生存时间明显短于高miR-34a水平的患者( P = 0.028和 P = 0.021)。此外,当使用多变量Cox回归模型进行分析时,低miR-34a水平与高复发率和较差的总体生存率显着相关。两者合计,我们的结果表明,胃癌中miR-34a的下调与复发率高和总生存期差有关,miR-34a可以作为胃癌的预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号